Important OptumRx updates to support providers, clinical staff and patients through COVID-19.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
September 14, 2017 – The FDA approved Nesher Pharmaceuticals’ AB-rated generic version of Genetech’s Tamiflu (oseltamivir phosphate) oral suspension.
Download PDF
Return to publications